Overview

Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC

Status:
Recruiting

Trial end date:
2023-11-01

Target enrollment:

Participant gender:

Summary

To determine the outcomes of patients with specific head and neck cancer after undergoing radiation therapy with atezolizumab followed by surgery then radiation with or without chemotherapy according to national guidelines.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University of Colorado, Denver

Collaborators:

Genentech, Inc.
National Cancer Institute (NCI)

Treatments:

Atezolizumab